A patient newly diagnosed with differentiated thyroid cancer is told, 'Do not worry—this is the good cancer.' What is the best consultant response?
NICE specifically advises against calling thyroid cancer a 'good cancer' because it can invalidate concern. Communication should cover prognosis, treatment burden, long-term hormone needs and uncertainties in language meaningful to the patient.
A. Repeat the phrase more emphatically to reassure: Repetition compounds minimisation and may undermine trust.
B. Give survival statistics without asking what matters to the patient: Numbers alone do not constitute supported decision-making or address individual concerns.
C. Acknowledge prognosis honestly while exploring the patient's concerns and avoiding the phrase 'good cancer': NICE specifically advises against calling thyroid cancer a 'good cancer' because it can invalidate concern. Communication should cover prognosis, treatment burden, long-term hormone needs and uncertainties in language meaningful to the patient.
D. Avoid discussing long-term effects until after surgery: Potential hypothyroidism, hypoparathyroidism, voice and swallowing effects belong in preoperative discussion.
E. Delegate all explanation to a leaflet: Written information supports but does not replace a personalised clinical conversation.
If the prognosis were uncertain or high risk, explicitly naming that uncertainty and arranging further discussion would be safer than false reassurance.
Independent Clinora educational preparation material; not official JCIE content, an accredited programme, clinical advice, or a substitute for local policy and specialist judgement.
Back to the Section 1 bank